Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loredana Vecchione

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
ESMO Open|June 25, 2019
Importance of genetic screens in precision oncologyAntonio Mulero-Sánchez, Ziva Pogacar, Loredana Vecchione
Targeted Oncology|May 7, 2013
Role of targeted agents in metastatic colorectal cancerHans Prenen, Loredana Vecchione, Eric Van Cutsem
Journal of Thoracic Disease|December 10, 2017
Should cT2 esophageal cancer get neoadjuvant treatment before surgery?Peter Thuss-Patience, Loredana Vecchione, Ulrich Keilholz
Expert Opinion on Investigational Drugs|May 27, 2009
Novel investigational drugs for gastric cancerLoredana Vecchione, Michele Orditura, Fortunato Ciardiello, et al.
Experimental Cell Research|September 20, 2011
EGFR-targeted therapyLoredana Vecchione, Bart Jacobs, Nicola Normanno, et al.
Nature Reviews. Clinical Oncology|November 16, 2011
Targeted therapies: how personal should we go?Miriam Martini, Loredana Vecchione, Salvatore Siena, et al.
ESMO Open|September 27, 2019
Liquid biopsy assessment of synchronous malignancies: a case report and review of the literatureSandra Liebs, Anika Nonnenmacher, Frederick Klauschen, et al.
ESMO Open|May 28, 2020
ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancerLoredana Vecchione, Sebastian Stintzing, George Pentheroudakis, et al.
Oncotargets and Therapy|February 5, 2013
Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancerRavit Geva, Loredana Vecchione, Sabine Tejpar, et al.
Oncology Reports|March 17, 2009
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysisMichele Orditura, Ferdinando De Vita, Gennaro Galizia, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
ESMO Open|June 25, 2019
Importance of genetic screens in precision oncologyAntonio Mulero-Sánchez, Ziva Pogacar, Loredana Vecchione
Targeted Oncology|May 7, 2013
Role of targeted agents in metastatic colorectal cancerHans Prenen, Loredana Vecchione, Eric Van Cutsem
Journal of Thoracic Disease|December 10, 2017
Should cT2 esophageal cancer get neoadjuvant treatment before surgery?Peter Thuss-Patience, Loredana Vecchione, Ulrich Keilholz
Expert Opinion on Investigational Drugs|May 27, 2009
Novel investigational drugs for gastric cancerLoredana Vecchione, Michele Orditura, Fortunato Ciardiello, et al.
Experimental Cell Research|September 20, 2011
EGFR-targeted therapyLoredana Vecchione, Bart Jacobs, Nicola Normanno, et al.
Nature Reviews. Clinical Oncology|November 16, 2011
Targeted therapies: how personal should we go?Miriam Martini, Loredana Vecchione, Salvatore Siena, et al.
ESMO Open|September 27, 2019
Liquid biopsy assessment of synchronous malignancies: a case report and review of the literatureSandra Liebs, Anika Nonnenmacher, Frederick Klauschen, et al.
ESMO Open|May 28, 2020
ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancerLoredana Vecchione, Sebastian Stintzing, George Pentheroudakis, et al.
Oncotargets and Therapy|February 5, 2013
Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancerRavit Geva, Loredana Vecchione, Sabine Tejpar, et al.
Oncology Reports|March 17, 2009
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysisMichele Orditura, Ferdinando De Vita, Gennaro Galizia, et al.
Pageof 4